Food and Drug Administration Commissioner Andrew von Eschenbach, center, flanked by Gerald J. Dal Pan, director of the Office of Drug Safety at the FDA, left, and Dr. John Jenkins, director, Office of New Drugs at the FDA, are sworn in on Capitol Hill in Washington, Wednesday, June 6, 2007, prior to... (Associated Press)